Global Coronary Stent Market - Focus on Bioabsorbable Stents Market Outlook 2024

Abstract
Stent is a miniscule mesh tube used for re-opening narrowed arteries from inside the vessel. Stenting is a minimally invasive procedure for treating coronary and peripheral artery disease. Stents are broadly classified into vascular and non-vascular stents. Vascular stents are mainly of three types- Coronary artery stents, peripheral vascular stents and neurovascular stents. The coronary artery stent is a vascular stent that is used for coronary atherosclerosis. Cardiovascular diseases are leading cause on deaths in majority of nations globally.

Growth of global coronary artery stents market is primarily attributed to prevalence of coronary and peripheral artery diseases, increasing geriatric population and favorable reimbursement policies. However, some of the factors restraining growth of the industry are stringent regulatory norms, high cost of devices, slow adoption rate and post-operative complications.

The report “Global Coronary Artery Stent – Focus on Bioresorbable Stents Market Outlook 2024” provides information on the current scenario, market outlook of the global coronary artery stents market with detailed analysis of bioresorbable stents. The market is further analyzed with detailed market outlook for global as well as regional markets such as North America, Europe and Asia Pacific. Future forecasts of vascular stents market overall and across various sub-segments has been provided till 2024, for all the geographies. Furthermore, major industry players have been prudently analyzed in the competitive landscape section of the report in order to provide key comparative insights.

Major industry players operating in the global coronary artery stents market includes Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, REVA Medical, Biotronik, Inc., among others. These players are profiled herein based on attributes such as business overview, product segments and financial analysis. It also compiles performance comparison of aforementioned companies and other leading companies in the segment based on various parameters in the competitive landscape section. In totality, the report provides detailed market analysis, with relevant forecasted data supported by key market dynamics. This information will be helpful in evaluating opportunities in global as well as regional coronary artery and bioresorbable stents market.

Content
1. Executive Summary
2. Research Methodology
3. Coronary Artery Stents
3.1 Background
3.2 Overview
3.3 Classification
3.3.1 Bare Metal Stent (BMS)
3.3.2 Drug-eluting stents (DES)
3.3.3 Bioresorbable stents (BRS)
4. Market Analysis
4.1 Market Sizing (Actual & Foreacsted)
4.2 Market Share Analysis
4.2.1 Market Share by Types
4.2.2 Market Share by Region
4.3 Pricing Trend
5. Bioresorbable Stents
5.1 Overview
5.2 Market Sizing (Actual & Forecasted)
5.3 Market Share Analysis
5.3.1 Market Share by Type of Material
5.3.2 Market Share by Application
5.3.3 Market Share by Absorption Rate
5.3.4 Market Share by Region
6. Regional Analysis
6.1 North America
6.1.1 Coronary Stent Market Sizing (Actual & Forecasted)
6.1.2 Market Share by Stent Type
6.1.3 Bioabsorbable Stent Market Sizing (Actual & Forecasted)
6.1.4 The US
6.1.4.1 Stent Market Sizing (Actual & Forecasted)
6.1.4.2 Market Share by Products
6.1.4.3 Bioabsorbable Stent Market Sizing (Actual & Forecasted)
6.2 Europe
6.2.1 Coronary Stent Market Sizing (Actual & Forecasted)
6.2.2 Market Share by Stent Type
6.2.3 Bioabsorbable Stent Market Sizing (Actual & Forecasted)
6.3 Asia Pacific
6.3.1 Coronary Stent Market Sizing (Actual & Forecasted)
6.3.2 Market Share by Stent Type
6.3.3 Bioabsorbable Stent Market Sizing (Actual & Forecasted)
7. Market Dynamics
7.1 Industry Trend & Development
7.1.1 Use of Premium Alloys for Stenting
7.1.3 Advent of X-Ray Visible Absorbable Embolic Bead
7.1.4 FDA Approval of First Dedicated Coronary Bifurcation Stent
7.2 Growth Drivers
7.2.1 Increasing Geriatric Population
7.2.2 Prevalence of Coronary & Peripheral Artery Diseases
7.2.3 Favorable Reimbursement Policies
7.3 Challenges
7.3.1 Stringent Regulations
7.3.2 Post-Operative Complications
7.3.3 Slow Adoption Rate
7.3.4 High Cost of Devices
8. Competitive Landscape
8.1 Coronary Stents
8.1.1 Market Share Analysis
8.2 Bioresorbable Stents
8.2.1 Market Share Analysis
8.2.2 Brand Analysis
9. Company Profiles
9.1 Abbott Laboratories
9.2 Medtronic PLC
9.3 Boston Scientific Corporation
9.4 REVA Medical
9.5 Biotronik Inc.